ArticleBJPsych open2026

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.

Zeina Beidas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.